Recent transaction and litigation

Home > Media Center > Recent transaction and litigation > 2024 > Cancer care startup C2i Genomics acquired by Veracyte for up to $95 million

2024 / January 2024

Cancer care startup C2i Genomics acquired by Veracyte for up to $95 million